Fit for a fracture

Medical Journal of Australia

Volumn 183, Issue 4, 2005, Pages 213-214

  Seymour, Hannah M ^a   Glendenning, Paul ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; ERGOCALCIFEROL; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VITAMIN D;

ADULT; BIOCHEMISTRY; CASE REPORT; DRUG BLOOD LEVEL; EPILEPSY; FALLING; FEMALE; FEMUR NECK FRACTURE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; MENTAL DISEASE; MENTAL HOSPITAL; NOTE; OLECRANON FRACTURE; PATIENT COMPLIANCE; SELF CARE; VITAMIN D DEFICIENCY;

EID: 23844494188     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb07001.x     Document Type: Note

References (12)

1. Lidgren L, Walloe A. Incidence of fractures in epileptics. Acta Orthop Scand 1977; 48: 356-361.
2. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-773.
3. Vestergaard P, Tigaran S, Rejnmark L, et al. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99: 269-275.
4. Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002; 58: 1348-1353.
5. Valimaki MJ, Tiihonen, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on anti-epileptic drugs. J Bone Miner Res 1994, 9: 631-637.
6. Tjellson L, Gotfredsen A, Christiansen C. Different actions of vitamin D2 and D3 on bone metabolism in patients treated with phenobarbitone/phenytoin. Calcif Tissue Int 1985; 37: 218-222.
7. Peterson P, Gray P, Tolman K. Calcium balance in drug-induced osteomalacia: response to vitamin D. Clin Pharmacol Ther 1976; 19: 63-67.
8. Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 1999; 47: 1195-1201.
9. Collins N, Maher J, Cole M, et al. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of devoloping antiepileptic drug-induced osteomalacia. Q J Med 1991; 78: 113-122.
10. Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 2001; 58: 1369-1374.
11. Heller HJ, Sakhaee K. Anticonvulsant-induced bone disease: a plea for monitoring and treatment. Arch Neurol 2001; 58: 1352-1353.
12. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-285.